Pioneering Stem Cell Biologist Dr. Rudolf Jaenisch, M.D., Joins Founding Scientific Team of Fate Therapeutics (Business Wire via Yahoo! Finance)
LA JOLLA, Calif. & CAMBRIDGE, Mass.—-Fate Therapeutics, Inc. announced today that Dr. Rudolf Jaenisch, M.D., founding member of the Whitehead Institute for Biomedical Research and professor in the Department of Biology, Massachusetts Institute of Technology, has joined the Company’s internationally recognized team of scientific founders dedicated to understanding stem cell biology in human …
[Read the full article here]Related News:
ImmunoCellular Therapeutics Identifies Novel Peptides to Broaden Applicability of Cancer Stem Cell Vaccine (Business Wire via Yahoo! Finance)
Fate Therapeutics Amasses More Academic Stem Cell IP with Children's Hospital Boston Deal
ProtoKinetix' AAGP is Critical for Stem Cell Therapy (Business Wire via Yahoo! Finance)